awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35603660-08D751A2-8CD8-4003-8AA6-7763B72B778B
Q35603660-08D751A2-8CD8-4003-8AA6-7763B72B778B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35603660-08D751A2-8CD8-4003-8AA6-7763B72B778B
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.
P2860
Q35603660-08D751A2-8CD8-4003-8AA6-7763B72B778B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35603660-08D751A2-8CD8-4003-8AA6-7763B72B778B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bffef8b59ccfab75c265071c0bf8d2aeb9b28809
P2860
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide.